Bank Of Montreal Selecta Biosciences Inc Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$0.96 - $1.6 $789,504 - $1.32 Million	-822,400 Reduced 77.97%	232,300 $262,000
Q3 2022 Nov 10, 2022	BUY	$1.33 - $2.6 $1.4 Million - $2.74 Million	1,054,700 New	1,054,700 $2.3 Million
Q4 2021 Feb 11, 2022	SELL	$2.89 - $4.43 $1.76 Million - $2.7 Million	-609,507 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.62 $849,559 - $1.17 Million	252,845 Added 70.89%	609,507 $2.69 Million
Q2 2021 Aug 12, 2021	BUY	$2.82 - $5.01 $1.01 Million - $1.79 Million	356,662 New	356,662 $1.78 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.